Recent introduction of 2 different lymphoma classifications has raised concerns about consistency in diagnosis, management, and clinical trial enrollment. Data from a large cohort reflecting real-world clinical practice suggest that differences between the classifications will affect <1% of non-Hodgkin lymphomas.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11561535 | PMC |
http://dx.doi.org/10.1182/blood.2024025681 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!